{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:27:27Z","timestamp":1772249247044,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.4158\/ep-2017-0247","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T10:32:41Z","timestamp":1523010761000},"page":"565-572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["EXOGENOUS TESTOSTERONE DOES NOT INDUCE OR EXACERBATE THE METABOLIC FEATURES ASSOCIATED WITH PCOS AMONG TRANSGENDER MEN"],"prefix":"10.1016","volume":"24","author":[{"given":"Kelly J.","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer J.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie D.","family":"Weinand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Safer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2017-0247_bb0010","first-page":"181","volume":"29","author":"Stein","year":"1935","journal-title":"Amenorrhoea associated with bilateral polycystic ovaries"},{"key":"10.4158\/EP-2017-0247_bb0015","first-page":"41","volume":"19","author":"Fauser","year":"2004","journal-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)"},{"key":"10.4158\/EP-2017-0247_bb0020","first-page":"2745","volume":"89","author":"Azziz","year":"2004","journal-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population"},{"key":"10.4158\/EP-2017-0247_bb0025","first-page":"48","volume":"91","author":"Ehrmann","year":"2006","journal-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome"},{"key":"10.4158\/EP-2017-0247_bb0030","first-page":"E628","volume":"98","author":"Moghetti","year":"2013","journal-title":"Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome"},{"key":"10.4158\/EP-2017-0247_bb0035","first-page":"295","volume":"77","author":"Wild","year":"2012","journal-title":"Dyslipidemia in PCOS"},{"key":"10.4158\/EP-2017-0247_bb0040","first-page":"467","volume":"37","author":"Rosenfield","year":"2016","journal-title":"The Pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited"},{"key":"10.4158\/EP-2017-0247_bb0045","first-page":"1328","volume":"79","author":"Barnes","year":"1994","journal-title":"Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women"},{"key":"10.4158\/EP-2017-0247_bb0050","first-page":"1","author":"Flores","year":"2016","journal-title":"How many adults identify as transgender in the United States?"},{"key":"10.4158\/EP-2017-0247_bb0055","first-page":"e1","volume":"107","author":"Meerwijk","year":"2017","journal-title":"Transgender population size in the United States: a meta-regression of population-based probability samples"},{"key":"10.4158\/EP-2017-0247_bb0060","first-page":"3869","volume":"102","author":"Hembree","year":"2017","journal-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine Society clinical practice guideline"},{"key":"10.4158\/EP-2017-0247_bb0065","first-page":"165","volume":"13","author":"Coleman","year":"2012","journal-title":"Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7"},{"key":"10.4158\/EP-2017-0247_bb0070","first-page":"2641","volume":"9","author":"Wierckx","year":"2012","journal-title":"Long-term evaluation of cross-sex hormone treatment in transsexual persons"},{"key":"10.4158\/EP-2017-0247_bb0075","first-page":"19","volume":"93","author":"Gooren","year":"2008","journal-title":"Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience"},{"key":"10.4158\/EP-2017-0247_bb0080","first-page":"265","volume":"79","author":"Polderman","year":"1994","journal-title":"Induction of insulin resistance by androgens and estrogens"},{"key":"10.4158\/EP-2017-0247_bb0085","first-page":"349","volume":"24","author":"Hampl","year":"1986","journal-title":"The use of andriol in treatment of androgen deficiency in trans-sexual women"},{"key":"10.4158\/EP-2017-0247_bb0090","first-page":"562","volume":"58","author":"Elbers","year":"2003","journal-title":"Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects"},{"key":"10.4158\/EP-2017-0247_bb0095","first-page":"3914","volume":"102","author":"Maraka","year":"2017","journal-title":"Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis"},{"key":"10.4158\/EP-2017-0247_bb0100","first-page":"1","volume":"72","author":"Elamin","year":"2010","journal-title":"Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta-analyses"},{"key":"10.4158\/EP-2017-0247_bb0105","first-page":"790","volume":"103","author":"Auer","year":"2018","journal-title":"Effects of sex hormone treatment on the metabolic syndrome in transgender individuals: focus on metabolic cytokines"},{"key":"10.4158\/EP-2017-0247_bb0110","first-page":"725","volume":"8","author":"Berra","year":"2006","journal-title":"Testosterone decreases adiponectin levels in female to male transsexuals"},{"key":"10.4158\/EP-2017-0247_bb0115","first-page":"795","volume":"161","author":"Jacobeit","year":"2009","journal-title":"Long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals"},{"key":"10.4158\/EP-2017-0247_bb0120","first-page":"3470","volume":"92","author":"Mueller","year":"2007","journal-title":"Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals"},{"key":"10.4158\/EP-2017-0247_bb0125","first-page":"2361","volume":"8","author":"Ott","year":"2011","journal-title":"Cross-sex hormone therapy alters the serum lipid profile: a retrospective cohort study in 169 transsexuals"},{"key":"10.4158\/EP-2017-0247_bb0130","first-page":"383","volume":"22","author":"Fernandez","year":"2016","journal-title":"Metabolic effects of hormone therapy in transgender patients"},{"key":"10.4158\/EP-2017-0247_bb0135","first-page":"605","volume":"125","author":"Deutsch","year":"2015","journal-title":"Effects of cross-sex hormone treatment on transgender women and men"},{"key":"10.4158\/EP-2017-0247_bb0140","first-page":"1004","volume":"47","author":"Nankin","year":"1987","journal-title":"Hormone kinetics after intramuscular testosterone cypionate"},{"key":"10.4158\/EP-2017-0247_bb0145","first-page":"2286","volume":"36","author":"Bullard","year":"2013","journal-title":"Secular changes in U.S. prediabetes prevalence defined by hemoglobin A1c and fasting plasma glucose: National Health and Nutrition Examination Surveys, 1999\u20132010"},{"key":"10.4158\/EP-2017-0247_bb0150","first-page":"361","volume":"22","author":"Bosinski","year":"1997","journal-title":"A higher rate of hyperandrogenic disorders in female-to-male transsexuals"},{"key":"10.4158\/EP-2017-0247_bb0155","first-page":"130","volume":"33","author":"Corona","year":"2015","journal-title":"Testosterone replacement therapy and cardiovascular risk: a review"},{"key":"10.4158\/EP-2017-0247_bb0160","first-page":"2536","volume":"95","author":"Bhasin","year":"2010","journal-title":"Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline"},{"key":"10.4158\/EP-2017-0247_bb0165","first-page":"5305","volume":"95","author":"Legro","year":"2010","journal-title":"Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism"},{"key":"10.4158\/EP-2017-0247_bb0170","first-page":"969","volume":"106","author":"Cohen","year":"2010","journal-title":"30-year trends in serum lipids among united states adults: results from the national health and nutrition examination surveys II, III, and 1999\u20132006"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2035343X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2035343X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:05:19Z","timestamp":1761516319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X2035343X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1530891X2035343X"],"URL":"https:\/\/doi.org\/10.4158\/ep-2017-0247","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EXOGENOUS TESTOSTERONE DOES NOT INDUCE OR EXACERBATE THE METABOLIC FEATURES ASSOCIATED WITH PCOS AMONG TRANSGENDER MEN","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2017-0247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}